AKT1 and diffuse large B-cell lymphoma: Similar to DNA-damaging agents [30,41], PDEis have been previously observed to activate AKT, for example, PDE4Bi in human diffuse large B cell lymphoma [42] and tadanafil (PDE5i) in murine ischemic injury [43].